Strides Arcolab to buy minority stake in Ascent Pharma

Published on Tue, Mar 16, 2010 at 10:02 |  Source : CNBC-TV18

Updated at Tue, Mar 16, 2010 at 14:21  

Like this story, share it with millions of investors on M3
0
0
Share on Tumblr
Arun Kumar, Group CEO and Vice Chairman, Strides Arcolab

Excerpts from Bazaar on CNBC-TV18 Watch the full show ยป

RELATED NEWS

Bangalore-based drug-maker Strides Arcolab has proposed to acquire a minority stake in Ascent Pharmahealth, which is listed on the Australian Stock Exchange. The deal values Ascent Pharmahealth at an enterprise value of 100 million Australian dollars.

Commenting on the latest development in the company, its Group CEO and Vice Chairman Arun Kumar said, Stride currently owns 57% in Ascent Pharmahealth and is expected to spend USD 30-35 million to acquire the remaining 43% stake. "The deal values Ascent at 7-7.5 times earnings before interest, taxes, depreciation, and amortization (EBITDA)."

Further he said the company plans to delist Ascent Pharma from the Australian Stock Exchange.

For complete interview, watch video.

  

Entities: Arun kumar
More on Moneycontrol

Trending News

Business News

Logitech ZAAG iPad2 Keyboard Case
Competition ahoy: Monkey 1, Sensex in neck-and-neck race "Competition ahoy: Monkey 1, Sensex in neck-and-neck race"

Sources Say BCCI Sahara Meet BCCI Agrees To All Other Demands Put In By Sahara

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 12 2012, 11:20

See more rally even if Greek crisis drags on: RBS

- in FII View

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 12 2012, 15:00 | Source: CNBC-TV18

Bosch sees 3-5% growth in 2012, bets big on India  

Feb 11 2012, 11:52 | Source: CNBC-TV18

TCS to expand centers in N.America; CY12 focus on Japan  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com